Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2656 AL 2670

Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder

Jakobsson J, Zetterberg H, Blennow K, Johan Ekman C, Johansson AG, Landén M.

Neuropsychopharmacology. 2013 Mar;38(4):664-72. doi: 10.1038/npp.2012.231. Epub 2012 Nov 6.

[Calcium hypothesis of Alzheimer disease]

Riazantseva MA, Mozhaeva GN, Kaznacheeva EV.

Usp Fiziol Nauk. 2012 Oct-Dec;43(4):59-72.

Potential blood biomarker for disease severity in the Taiwanese population with Alzheimer's disease

Huang CW, Wang SJ, Wu SJ, Yang CC, Huang MW, Lin CH, Cheng IH.

Am J Alzheimers Dis Other Demen. 2013 Feb;28(1):75-83. doi: 10.1177/1533317512467674. Epub 2012 Dec 10.

mCiRNA-synaptic crystal ball?

Bredesen D.

Aging (Albany NY). 2012 Nov;4(11):732-3. doi: 10.18632/aging.100511.

Plasma viscosity: is a biomarker for the differential diagnosis of Alzheimer's disease and vascular dementia?

Aras S, Tek I, Varli M, Yalcin A, Cengiz OK, Atmis V, Atli T.

Am J Alzheimers Dis Other Demen. 2013 Feb;28(1):62-8. doi: 10.1177/1533317512467682. Epub 2012 Dec 14.

Research and standardization in Alzheimer's trials: reaching international consensus

Carrillo MC, Rowe CC, Szoeke C, Masters CL, Ames D, O'Meara T, Macaulay SL, Milner A, Ellis KA, Maruff P, Rainey-Smith SR, Martins RN, Bain LJ, Head RJ; NIA/Alzheimer Association and International Working Group.

Alzheimers Dement. 2013 Mar;9(2):160-8. doi: 10.1016/j.jalz.2012.10.006. Epub 2012 Dec 23.

[Early evaluation of Alzheimer's disease: biomarkers and neuropsychological tests]

Lanfranco RG, Manríquez-Navarro P, Avello LG, Canales-Johnson A.

Rev Med Chil. 2012 Sep;140(9):1191-200. doi: 10.4067/S0034-98872012000900014.

[Exploring the early diagnostic biomarkers for Alzheimer's disease]

Yamasaki T, Tobimatsu S.

Fukuoka Igaku Zasshi. 2012 Nov;103(11):215-25.

Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's disease

Marcello A, Wirths O, Schneider-Axmann T, Degerman-Gunnarsson M, Lannfelt L, Bayer TA.

Neurobiol Aging. 2011 Aug;32(8):1379-87. doi: 10.1016/j.neurobiolaging.2009.08.011. Epub 2009 Sep 24.

Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis

Whitwell JL, Jack CR Jr, Przybelski SA, Parisi JE, Senjem ML, Boeve BF, Knopman DS, Petersen RC, Dickson DW, Josephs KA.

Neurobiol Aging. 2011 Sep;32(9):1531-41. doi: 10.1016/j.neurobiolaging.2009.10.012. Epub 2009 Nov 14.

Histological and direct evidence for the role of complement in the neuroinflammation of AD

Veerhuis R.

Curr Alzheimer Res. 2011 Feb;8(1):34-58. doi: 10.2174/156720511794604589.

Increasing the predictive accuracy of amyloid-β blood-borne biomarkers in Alzheimer's disease

Watt AD, Perez KA, Faux NG, Pike KE, Rowe CC, Bourgeat P, Salvado O, Masters CL, Villemagne VL, Barnham KJ.

J Alzheimers Dis. 2011;24(1):47-59. doi: 10.3233/JAD-2010-101722.

Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease

Varges D, Jung K, Gawinecka J, Heinemann U, Schmitz M, von Ahsen N, Krasnianski A, Armstrong VW, Zerr I.

J Alzheimers Dis. 2011;23(4):717-26. doi: 10.3233/JAD-2010-101527.

Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease

Sagare AP, Deane R, Zetterberg H, Wallin A, Blennow K, Zlokovic BV.

J Alzheimers Dis. 2011;24(1):25-34. doi: 10.3233/JAD-2010-101248.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias